Skip to main content

Pemphigus — Deal Benchmarks & Valuation

Median Upfront
$581M
Range: $308M - $840M
Total Deal Value
$3.0B
Range: $1.9B - $4.2B
Royalty Rate
14% - 23.4%
Tiered up to 27.4%
Dev Milestones
$489M
Range: $314M - $667M
Model Your Deal

Market Analysis

Pemphigus is one of the most actively transacted indications in immunology licensing. Phase 2 deals for pemphigus carry a median total deal value of $3.0B, with upfront payments ranging from $308M to $840M. The recommended deal structure allocates approximately 19% to upfront payments and 81% to milestones.

Milestone structures for pemphigus deals allocate $489M to development milestones, $856M to regulatory milestones, and $1.1B to commercial milestones. Royalty rates range from 14% to 23.4% at the base tier, with tiered escalation reaching 18%-27.4% on peak sales.

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

What are typical deal terms for pemphigus licensing?
Phase 2 pemphigus licensing deals average $581M in upfront payments with $3.0B total deal value. The 19/81 upfront/milestone split reflects the risk profile at this clinical stage.
What royalty rates are standard for pemphigus deals?
Base royalty rates for pemphigus transactions range from 14% to 23.4%, with tiered escalations reaching 18%-27.4% on peak sales. Rates are influenced by mechanism differentiation, competitive positioning, and territorial scope.
How are pemphigus deal milestones structured?
Pemphigus deals allocate approximately 81% of total deal value to milestones. Development milestones ($489M) make up the largest share, followed by commercial milestones ($1.1B) and regulatory milestones ($856M).
PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

Start 7-Day Free Trial

$299/mo after trial · Cancel anytime

Related Benchmarks

Rheumatoid Arthritis Deals

View

Systemic Lupus (SLE) Deals

View

Lupus Nephritis Deals

View

Immunology Deal Overview

View

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 1,600+ biopharma licensing deals.

Start Calculating
For Funds & Advisors

Need the full deal landscape?

The Deal Intelligence Brief covers every modality and deal structure for this indication — 52 deal calculations, AI strategic narrative, comparable transactions, partner matching, and white-label branding. Delivered in 24 hours.

Configure Brief — $2,500All-inclusive · White-label · Walkthrough included